Manzo Pharmaceuticals, Inc — Form D
Manzo Pharmaceuticals, Inc of Toronto, A6, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-10. Industry: Pharmaceuticals.
Offering
- Filed: 2015-12-10
- Form: D
- Accession: 0001637132-15-000003
- Industry: Pharmaceuticals
- Exemptions: 06c
- Minimum investment: $1K
- Security types: equity, debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-252734
Issuer
- Name: Manzo Pharmaceuticals, Inc
- CIK: 0001637132
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 222-415 Oakdale Road, Toronto, A6, M3N 1W7
- Phone: 647-393-8417
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Arthur Douglas Smitherman | Director | Toronto, Z4 |
More